DE69724148D1 - 3-aryl-2-(1-substitutiert-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazolderivate, ihre herstellung und ihre verwendung als modulatoren der neurotransmitter-funktion - Google Patents

3-aryl-2-(1-substitutiert-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazolderivate, ihre herstellung und ihre verwendung als modulatoren der neurotransmitter-funktion

Info

Publication number
DE69724148D1
DE69724148D1 DE69724148T DE69724148T DE69724148D1 DE 69724148 D1 DE69724148 D1 DE 69724148D1 DE 69724148 T DE69724148 T DE 69724148T DE 69724148 T DE69724148 T DE 69724148T DE 69724148 D1 DE69724148 D1 DE 69724148D1
Authority
DE
Germany
Prior art keywords
piperidinyl
benzo
modulators
oxo
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69724148T
Other languages
English (en)
Other versions
DE69724148T2 (de
Inventor
H Merriman
S Rauckman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69724148D1 publication Critical patent/DE69724148D1/de
Publication of DE69724148T2 publication Critical patent/DE69724148T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69724148T 1996-12-23 1997-11-13 3-aryl-2-(1-substitutiert-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazolderivate, ihre herstellung und ihre verwendung als modulatoren der neurotransmitter-funktion Expired - Fee Related DE69724148T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77486696A 1996-12-23 1996-12-23
US774866 1996-12-23
PCT/US1997/021178 WO1998028295A1 (en) 1996-12-23 1997-11-13 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function

Publications (2)

Publication Number Publication Date
DE69724148D1 true DE69724148D1 (de) 2003-09-18
DE69724148T2 DE69724148T2 (de) 2004-06-09

Family

ID=25102528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69724148T Expired - Fee Related DE69724148T2 (de) 1996-12-23 1997-11-13 3-aryl-2-(1-substitutiert-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazolderivate, ihre herstellung und ihre verwendung als modulatoren der neurotransmitter-funktion

Country Status (17)

Country Link
EP (1) EP0956287B1 (de)
JP (1) JP3282827B2 (de)
KR (1) KR20000062283A (de)
AR (1) AR009440A1 (de)
AT (1) ATE247111T1 (de)
AU (1) AU716689B2 (de)
BR (1) BR9714432A (de)
CA (1) CA2273181C (de)
DE (1) DE69724148T2 (de)
DK (1) DK0956287T3 (de)
ES (1) ES2200205T3 (de)
HU (1) HUP9904071A3 (de)
IL (1) IL130605A0 (de)
NO (1) NO993085L (de)
PT (1) PT956287E (de)
WO (1) WO1998028295A1 (de)
ZA (1) ZA9711337B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1393351B1 (it) * 2009-03-16 2012-04-20 Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2509797C2 (de) * 1975-03-06 1985-07-18 Dr. Karl Thomae Gmbh, 7950 Biberach Phthalimidine, deren physiologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT345806B (de) * 1975-03-06 1978-10-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer substituierter arylalkylamine und deren salze
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors

Also Published As

Publication number Publication date
PT956287E (pt) 2003-11-28
DE69724148T2 (de) 2004-06-09
EP0956287B1 (de) 2003-08-13
HUP9904071A3 (en) 2000-07-28
AU716689B2 (en) 2000-03-02
AR009440A1 (es) 2000-04-12
CA2273181C (en) 2004-01-20
DK0956287T3 (da) 2003-11-24
IL130605A0 (en) 2000-06-01
WO1998028295A1 (en) 1998-07-02
ATE247111T1 (de) 2003-08-15
KR20000062283A (ko) 2000-10-25
HUP9904071A2 (hu) 2000-05-28
EP0956287A1 (de) 1999-11-17
ZA9711337B (en) 1998-06-23
ES2200205T3 (es) 2004-03-01
NO993085L (no) 1999-08-20
AU5358898A (en) 1998-07-17
CA2273181A1 (en) 1998-07-02
JP2001520641A (ja) 2001-10-30
JP3282827B2 (ja) 2002-05-20
NO993085D0 (no) 1999-06-22
BR9714432A (pt) 2000-05-02

Similar Documents

Publication Publication Date Title
ATE259806T1 (de) 8-azabicyclo 3.2.1)octan-, 8-azabicyclo 3.2.1)oct-6-en-, 9-azabicyclo 3.3.1)nonan-, 9-aza-3- oxabicyclo 3.3.1)nonan- und 9-aza-3-thiabicyclo 3.3.1)nonan-derivate, ihre herstellung und ihre verwendung als insektizide
DE69532495D1 (de) Oxazolidindion-Derivate, ihre Herstellung und Verwendung
ATE286021T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE69923859D1 (de) Porphyrin-verbindungen, ihre konjugate und test-methoden basierend auf der verwendung besagter konjugate
DE69817611D1 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
DE122008000020I1 (de) Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
DE59710422D1 (de) Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
DE69019550T2 (de) Piperidin-Derivate, ihre Herstellung und ihre Verwendung.
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
DE69726529D1 (de) Benzoxazolderivate und ihre Verwendung als UV-Filter
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
ATE243682T1 (de) Heterozyklisch substituierte biphenylamid derivate, deren herstellung und deren verwendung als fungizide
DE59404704D1 (de) Faserreaktive Farbstoffe, ihre Herstellung und Verwendung
DE69821623D1 (de) Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament
DE59403353D1 (de) Faserreaktive Farbstoffe, ihre Herstellung und Verwendung
DE69625857D1 (de) Siliconderivate, ihre Herstellung und Verwendung
DE69521595T2 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
ATE242770T1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
DE68906687D1 (de) 4-amino-3-acylchinolin-derivate, und ihre verwendung als inhibitioren der magensekretion.
DE59409541D1 (de) Bicyclen-derivate, ihre herstellung und verwendung
DE69723463D1 (de) Cyclische organoselenderivate, ihre herstellung und verwendung
DE69420095T2 (de) Derivate von Polysacchariden, ihre Herstellung und Verwendung
DE59712148D1 (de) 1,3-dimethyl-5-fluor-pyrazol-4-carboxamide derivative, deren herstellung und deren verwendung als mikrobizide
DE59501950D1 (de) Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
DE59504605D1 (de) Monoazofarbstoffe, ihre Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8339 Ceased/non-payment of the annual fee